The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Perioperative pembrolizumab (pembro) plus chemotherapy (chemo) for locally advanced gastric or gastroesophageal junction (G/GEJ) cancer: Asia versus non-Asia subgroup analysis of KEYNOTE-585.
 
Takashi Oshima
No Relationships to Disclose
 
Kohei Shitara
Honoraria - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Janssen; Lilly; Ono Pharmaceutical
Consulting or Advisory Role - ALX Oncology; Amgen; Arcus Biosciences Inc.; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Daiichi Sankyo; GlaxoSmithKline K.K.; Guardant Health; Healios; Janssen; Moderna.Inc; MSD; Novartis; Ono Pharmaceutical; Takeda; Zymeworks
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Eisai (Inst); MSD (Inst); Ono Pharmaceutical (Inst); PPD-SNBL (Inst); PRA Health Sciences (Inst); Taiho Pharmaceutical (Inst); Toray Industries (Inst)
 
Hisateru Yasui
Honoraria - Bristol-Myers Squibb Japan; Chugai Pharma; Eisai; JMS; MSD; Ono Pharmaceutical; Taiho Pharmaceutical; Yakult Honsha
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Daiichi Sankyo (Inst); MSD (Inst); Ono Pharmaceutical (Inst)
 
Hiroshi Yabusaki
No Relationships to Disclose
 
Young-Kyu Park
No Relationships to Disclose
 
Takaki Yoshikawa
Honoraria - Astellas Pharma; AstraZeneca; BMS; Chugai Pharma; Daiichi Sankyo; Intuitive Surgical; Johnson & Johnson/Janssen; Medtronic; Olympus; Ono Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - MSD Oncology; TERUMO
Research Funding - Lilly
 
Kun-Huei Yeh
Honoraria - Amgen; Bristol-Myers Squibb; Daiichi Sankyo; Merck; MSD; Novartis; Ono Pharmaceutical; Pfizer; Roche; Takeda; TTY Biopharm
Consulting or Advisory Role - AstraZeneca; Bayer; Daiichi Sankyo; Daiichi Sankyo/Astra Zeneca; Daiichi Sankyo/Astra Zeneca; DSI/AZ; MSD; MSD; Novartis; Pfizer; Pierre Fabre; Takeda
Travel, Accommodations, Expenses - Ono Pharmaceutical; Pfizer; Takeda
 
Chia Jui Yen
No Relationships to Disclose
 
Yongjian Zhou
No Relationships to Disclose
 
Wei-Peng Yong
Consulting or Advisory Role - Abbvie/Genentech; Amgen; Astellas Pharma; AstraZeneca
Speakers' Bureau - AstraZeneca; BMS; DKSH; Eisai; Merck KGaA; MSD Oncology; Taiho Oncology
Research Funding - Amgen (Inst); AstraZeneca (Inst); BMS (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Experimental Drug Development Centre (EDDC)/A*STAR (Inst); MSD (Inst); Novartis (Inst); SCG Cell Therapy (Inst)
 
Matthew Ng
Stock and Other Ownership Interests - Amgen; AstraZeneca; GlaxoSmithKline
Honoraria - Amgen; Astellas Pharma; AstraZeneca/Daiichi Sankyo; MSD Oncology
Consulting or Advisory Role - Amgen; Astellas Pharma; BeiGene; MSD Oncology
Speakers' Bureau - MSD Oncology
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca
 
Gwo Fuang Ho
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Boehringer Ingelheim; MSD; Novartis; Pfizer; Roche; Tadeka
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Eisai; Merck; MSD; Novartis; Pfizer; Roche
Research Funding - AB Science (Inst); Amgen (Inst); Arcus Biosciences (Inst); Astellas Pharma (Inst); AstraZeneca/Daiichi Sankyo (Inst); Boehringer Ingelheim (Inst); EliLily (Inst); Janssen Research & Development (Inst); Merck Sharp & Dohme (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Regeneron (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol Myers Squibb; Dr Reddy’s; Ipsen; MSD Oncology; Pfizer; Regeneron; Roche Sequencing Solutions; SERVIER; Zullig Pharma
 
Rubi Li
Consulting or Advisory Role - AstraZeneca/Merck; MSD; Novartis; ZPT Eli Lilly; ZPT-Amgen
 
Xiao Fang
Employment - Merck
 
Pierre LeConte
Employment - MSD Oncology
Stock and Other Ownership Interests - MSD Oncology
Travel, Accommodations, Expenses - MSD Oncology
 
Pooja Bhagia
Employment - Merck
 
Sun Young Rha
Consulting or Advisory Role - Amgen; Arcus Biosciences; Astellas Pharma; AstraZeneca; Daiichi Sankyo; Eisai; indivumed; LG Chem; MSD Oncology; Ono Pharmaceutical; Toray Industries
Speakers' Bureau - Amgen; Arcus Biosciences; Astellas Pharma; AstraZeneca; BMS/Ono; Daiichi Sankyo/UCB Japan; Eisai; MSD Oncology
Research Funding - Amgen (Inst); ASLAN Pharmaceuticals; Astellas Pharma; AstraZeneca; Bayer; BeiGene; Bristol-Myers Squibb; Daichii Sankyo; Eisai; Indivumed; Lilly; MSD Oncology; Roche/Genentech; Sillajen; Zymeworks